Altered Serum Levels of Adipokines and Insulin in Probable Alzheimer's Disease

被引:87
|
作者
Khemka, Vineet Kumar [1 ]
Bagchi, Debajit [1 ]
Bandyopadhyay, Kausik [1 ]
Bir, Aritri [1 ]
Chattopadhyay, Mrittika [1 ]
Biswas, Atanu [2 ]
Basu, Debasis [1 ]
Chakrabarti, Sasanka [1 ]
机构
[1] Inst Post Grad Med Educ & Res, Dept Biochem, Kolkata 700020, India
[2] Bangur Inst Neurosci BIN, Dept Neuromed, Kolkata, India
关键词
Adiponectin; Alzheimer's disease; amyloid-beta; insulin; leptin; RISK-FACTOR; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; ADIPONECTIN RECEPTORS; NATIONAL INSTITUTE; CHOLESTEROL LEVEL; APOE GENOTYPE; PLASMA LEPTIN; STATIN USE; HYPERCHOLESTEROLEMIA;
D O I
10.3233/JAD-140006
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cerebral hypometabolism of glucose, weight loss, and decreased food intake are characteristic features of sporadic Alzheimer's disease (AD). A systematic study on the serum levels of adipokines and insulin, the major hormones regulating energy metabolism, food intake, and body weight, in sporadic AD is necessary. The present study compares the serum levels of leptin, adiponectin, and insulin, measured by commercially available immuno-assay kits, between controls and sporadic AD subjects. The results show a conspicuous decrease in the level of leptin, a dramatic rise in the level of adiponectin, and also a statistically significant increase in insulin level, in the blood of AD subjects, with respect to controls. The changes in the serum levels of adiponectin and insulin in AD are positively correlated with the severity of dementia. Likewise, the serum level of leptin in AD subjects is negatively correlated with the degree of dementia. The changes in the levels of adipokines and insulin have implications in the amyloid pathology, neurodegeneration, and hypometabolism of glucose existing in the AD brain.
引用
收藏
页码:525 / 533
页数:9
相关论文
共 50 条
  • [31] HAIR AND SERUM TRACE ELEMENT LEVELS IN ALZHEIMER'S DISEASE
    Koc, Emine R.
    Ayturk, Zubeyde
    Ilhan, Atilla
    Acar, Burcu
    Gurler, Mukaddes
    Bodur, M. Said
    [J]. NEUROBIOLOGY OF AGING, 2014, 35 (03) : 723 - 723
  • [32] The interaction of serum folate and estradiol levels in Alzheimer's disease
    Hogervorst, E
    Smith, AD
    [J]. NEUROENDOCRINOLOGY LETTERS, 2002, 23 (02) : 155 - 160
  • [33] Serum sEPCR Levels Are Elevated in Patients With Alzheimer's Disease
    Zhu, Yongjian
    Chen, Zhilong
    Chen, Xugang
    Hu, Sheng
    [J]. AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2015, 30 (05): : 517 - 521
  • [34] Elevated serum copper and ceruloplasmin levels in Alzheimer's disease
    Park, Jun-Hyun
    Lee, Dong-Woo
    Park, Kyung Soo
    [J]. ASIA-PACIFIC PSYCHIATRY, 2014, 6 (01) : 38 - 45
  • [35] Serum Clusterin Levels Are Not Increased in Presymptomatic Alzheimer's Disease
    Ijsselstijn, Linda
    Dekker, Lennard J. M.
    Koudstaal, Peter J.
    Hofman, Albert
    Smitt, Peter A. E. Sillevis
    Breteer, Monique M. B.
    Luider, Theo M.
    [J]. JOURNAL OF PROTEOME RESEARCH, 2011, 10 (04) : 2006 - 2010
  • [36] Serum adiponectin levels change in a course of Alzheimer's disease
    Baranowska-Bik, A.
    Bik, W.
    Kalisz, M.
    Wolinska-Witort, E.
    Styczynska, M.
    Chodakowska, M.
    Barcikowska, M.
    Baranowska, B.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S546 - S546
  • [37] Circulating levels of adipokines in Parkinson's disease
    Rocha, Natalia Pessoa
    Scalzo, Paula Luciana
    Barbosa, Izabela Guimaraes
    de Sousa, Mariana Soares
    Morato, Isabela Boechat
    Marciano Vieira, Erica Leandro
    Christo, Paulo Pereira
    Reis, Helton Jose
    Teixeira, Antonio Ludo
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 339 (1-2) : 64 - 68
  • [38] Metabolic Dysregulation in Probable Alzheimer's Disease
    Reading, Christopher L.
    Ahlem, Clarence
    Palumbo, Joseph M.
    Testa, Marcia A.
    Simonson, Donald C.
    [J]. DIABETES, 2023, 72
  • [39] SPECT patterns in probable Alzheimer’s disease
    H. Müller
    H.-J. Möller
    A. Stippel
    M. Fric
    F. Grünwald
    G. Laux
    E. Klemm
    H.-J. Biersack
    [J]. European Archives of Psychiatry and Clinical Neuroscience, 1999, 249 : 190 - 196
  • [40] PLASMA LEVELS OF LIPOPROTEIN (A) AND APOLIPOPROTEIN A1 IN PATIENTS WITH PROBABLE ALZHEIMER'S DISEASE
    Politis, Antonios
    Katirtzoglou, Everina
    Stamouli, Evagelia
    Piperi, Christina
    Passa, Maria
    Politis, Tassos
    Papageorgiou, Charalambos
    [J]. NEUROBIOLOGY OF AGING, 2016, 39 : S20 - S20